# Adventris Pharmaceuticals

Source: https://onco.cc/companies/adventris-pharmaceuticals/  
OnCo record `adventris-pharmaceuticals` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Adventris Pharmaceuticals, a Johns Hopkins spin-out, develops off-the-shelf cancer vaccines designed to raise immune responses against mutant KRAS, the driver mutation shared by pancreatic, colorectal and lung cancers, with the long-term aim of a yearly vaccine that prevents those cancers before they form. Its programmes are preclinical or early clinical.

## Summary

Adventris Pharmaceuticals, a Johns Hopkins spin-out, develops off-the-shelf therapeutic and preventive cancer vaccines using a platform designed to raise strong immune responses against poorly immunogenic oncogene-derived antigens. Its first vaccine targets mutant KRAS, relevant to pancreatic, colorectal and lung cancers, and the company's stated long-term vision is annual pan-cancer vaccination. Programmes are preclinical or early clinical; no sourced financing rounds are recorded here.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- Tags: yc
- HQ: Baltimore, MD
- Type: biotech
- Website: https://adventris.com

## Sources

- Y Combinator profile: https://www.ycombinator.com/companies/adventris-pharmaceuticals
- Official website: https://adventris.com

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/), [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- fronts: [Immunotherapy](https://onco.cc/fronts/immunotherapy/), [Prevention & Risk](https://onco.cc/fronts/prevention/)
- technologies: [Off-the-shelf cancer vaccines](https://onco.cc/technologies/shared-antigen-vaccine/)
- targets: [KRAS](https://onco.cc/targets/kras/)
- companies: [Y Combinator](https://onco.cc/companies/y-combinator/)

---
JSON: https://onco.cc/api/v1/entities/adventris-pharmaceuticals.json